Analysts Set Select Medical Holdings Co. (NYSE:SEM) PT at $34.25

Select Medical Holdings Co. (NYSE:SEM) has received a consensus recommendation of “Moderate Buy” from the four analysts that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $34.25.

A number of research analysts have recently weighed in on SEM shares. Benchmark restated a “buy” rating and issued a $39.00 price target on shares of Select Medical in a research report on Friday, May 3rd. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, March 22nd. Finally, Royal Bank of Canada raised their price objective on shares of Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research note on Monday, May 6th.

Insiders Place Their Bets

In other Select Medical news, Chairman Robert A. Ortenzio sold 50,000 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the transaction, the chairman now owns 6,689,668 shares of the company’s stock, valued at approximately $200,021,073.20. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 19.14% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Select Medical

Several hedge funds have recently modified their holdings of SEM. Comerica Bank increased its stake in Select Medical by 30.0% during the first quarter. Comerica Bank now owns 68,485 shares of the health services provider’s stock worth $2,065,000 after acquiring an additional 15,824 shares during the last quarter. Tidal Investments LLC purchased a new stake in shares of Select Medical during the 1st quarter worth about $467,000. 8 Knots Management LLC acquired a new stake in Select Medical during the 1st quarter worth approximately $4,917,000. Price T Rowe Associates Inc. MD raised its holdings in Select Medical by 0.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,202,219 shares of the health services provider’s stock valued at $518,647,000 after buying an additional 90,604 shares during the period. Finally, BOKF NA purchased a new stake in Select Medical during the first quarter worth approximately $262,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Stock Performance

NYSE:SEM opened at $32.93 on Thursday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical has a fifty-two week low of $21.28 and a fifty-two week high of $35.08. The firm’s fifty day simple moving average is $30.09 and its 200-day simple moving average is $27.06. The stock has a market cap of $4.28 billion, a PE ratio of 15.68, a price-to-earnings-growth ratio of 1.57 and a beta of 1.38.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, May 2nd. The health services provider reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.55 by $0.22. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. The company had revenue of $1.79 billion during the quarter, compared to the consensus estimate of $1.70 billion. Analysts expect that Select Medical will post 2.1 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 30th. Stockholders of record on Thursday, May 16th will be given a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date is Wednesday, May 15th. Select Medical’s dividend payout ratio is presently 23.81%.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.